The inflammatory profile of CTD-PAH patients was separated from CTEPH patients by Dim1, to which particularly IL-10, CXCL9 and CXCL13 levels contributed (Fig. 4c, d). This evidence concerns the gene CXCL13 and chronic thromboembolic pulmonary hypertension.